12 Oct 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Market Wizards B.V. and Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
09 Oct 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Market Wizards B.V.
|
20103010 Biotechnology |
Change in Capital |
08 Oct 2026
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
30 Sep 2026
20:00 CEST |
OXURION |
Oxurion Publishes First Half 2026 Results
|
20103010 Biotechnology |
Sales, Income, Commercial results |
30 Sep 2026
20:00 CEST |
OXURION |
Oxurion publie ses résultats du premier semestre 2026
|
20103010 Biotechnology |
Sales, Income, Commercial results |
30 Sep 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC, The Goldman Sachs Group, Inc and Goldman Sachs International
|
20103010 Biotechnology |
Legal |
30 Sep 2026
08:00 CEST |
OXURION |
Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
|
20103010 Biotechnology |
Legal |
30 Sep 2026
08:00 CEST |
OXURION |
Oxurion entre en négociations exclusives en vue d'acquérir les activités et les actifs d'Eclevar, une CRO spécialisée dans les MedTech
|
20103010 Biotechnology |
Legal |
23 Sep 2026
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
14 Sep 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
10 Sep 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
21 Jul 2026
08:00 CEST |
OXURION |
Oxurion élargit sa plateforme de recherche clinique grâce à un partenariat stratégique en biométrie entre Axiodis CRO et KYomed INNOV
|
20103010 Biotechnology |
Legal |
21 Jul 2026
08:00 CEST |
OXURION |
Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
|
20103010 Biotechnology |
Legal |
14 Jul 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
08 Jul 2026
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Legal |
06 Jul 2026
18:30 CEST |
OXURION |
Oxurion franchit une nouvelle étape dans le développement de sa plateforme Exagis avec le lancement commercial de son module eTMF
|
20103010 Biotechnology |
Legal |
06 Jul 2026
18:30 CEST |
OXURION |
Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module
|
20103010 Biotechnology |
Legal |
26 Jun 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
24 Jun 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
19 Jun 2026
15:45 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Legal |
15 Jun 2026
19:30 CEST |
OXURION |
Major market validation: Pierre Fabre Laboratories uses Oxurion's Exagis Platform
|
20103010 Biotechnology |
Legal |
15 Jun 2026
19:30 CEST |
OXURION |
Validation majeure du marché : les Laboratoires Pierre Fabre utilisent la plateforme Exagis d'Oxurion
|
20103010 Biotechnology |
Legal |
10 Jun 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
10 Jun 2026
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
08 Jun 2026
21:00 CEST |
OXURION |
Oxurion launches a software-driven growth strategy with Exagis
|
20103010 Biotechnology |
Legal |
08 Jun 2026
21:00 CEST |
OXURION |
Oxurion lance une stratégie de croissance axée sur le logiciel avec Exagis
|
20103010 Biotechnology |
Legal |
03 Jun 2026
18:00 CEST |
OXURION |
Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
03 Jun 2026
18:00 CEST |
OXURION |
Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
02 Jun 2026
18:00 CEST |
OXURION |
Oxurion étend ses compétences pour répondre à la demande croissante de services de recherche clinique dédiés aux GLP-1 et aux peptides
|
20103010 Biotechnology |
Legal |
02 Jun 2026
18:00 CEST |
OXURION |
Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services
|
20103010 Biotechnology |
Legal |
02 Jun 2026
08:00 CEST |
OXURION |
Oxurion - arrêt du projet de CRO française (LOI du 13/10/25) et priorité à la cible internationale (LOI du 19/03/26)
|
20103010 Biotechnology |
Legal |
02 Jun 2026
08:00 CEST |
OXURION |
Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)
|
20103010 Biotechnology |
Legal |
29 May 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
29 May 2026
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
27 May 2026
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
27 May 2026
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
26 May 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
26 May 2026
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
05 May 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
05 May 2026
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Apr 2026
18:30 CEST |
OXURION |
Publication Annual Report - Annual Shareholders Meeting
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
30 Apr 2026
18:30 CEST |
OXURION |
Publicatie jaarverslag Jaarlijkse Algemene Vergadering
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
16 Apr 2026
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
16 Apr 2026
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
07 Apr 2026
18:00 CEST |
OXURION |
Uitstel Gewone Algemene Vergadering
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
07 Apr 2026
18:00 CEST |
OXURION |
Postponement Annual Shareholders Meeting
|
20103010 Biotechnology |
General meeting / Board Meeting, Meetings / events |
19 Mar 2026
18:30 CET |
OXURION |
Oxurion signe une lettre d'intention pour l'acquisition d'une CRO internationale
|
20103010 Biotechnology |
Legal |
19 Mar 2026
18:30 CET |
OXURION |
Oxurion signs a letter of intent for the acquisition of an international CRO
|
20103010 Biotechnology |
Legal |
18 Mar 2026
18:00 CET |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
18 Mar 2026
18:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |